All Stories

  1. Ocular Mucous Membrane Pemphigoid
  2. Clinical Course and Outcomes of Autoimmune Versus Non-Autoimmune Surgically Induced Scleral Necrosis: A Multicentric Comparative Study
  3. Outcomes of accelerated corneal cross-linking for pediatric and adult keratoconus: a comparative study
  4. The visual impact of higher-order aberrations in patients with pediatric blepharokeratoconjunctivitis
  5. Actinic conjunctivitis and its relationship with prurigo in an indigenous population from the Highlands of Chiapas, Mexico
  6. Definition and Diagnostic Criteria for Pediatric Blepharokeratoconjunctivitis
  7. Reply to Letter to the Editor: Correlation and Level of Agreement between the Ocular Surface Disease Index and the Symptom Assessment in Dry Eye Questionnaires: A Survey-Based Study
  8. Wessely corneal ring phenomenon: An unsolved pathophysiological dilemma
  9. Correlation and Level of Agreement between the Ocular Surface Disease Index and the Symptom Assessment in Dry Eye Questionnaires: A Survey-Based Study
  10. CASE REPORTS: Challenges in the diagnosis and management of simultaneous bilateral toxic anterior segment syndrome after phacorefactive surgery
  11. Regarding Kaya P et al. “Predictive Factors for the Prognosis of Vogt-Koyanagi-Harada Disease”
  12. Practice patterns in the management of bacterial keratitis: a five-continent survey
  13. Letter Regarding: Clinical Characteristics and Therapeutic Outcomes of Pediatric Blepharokeratoconjunctivitis
  14. Authors’ response: Brusini and Papa's comments regarding our review article entitled: “Pigment dispersion syndrome and its implications for glaucoma”
  15. Authors’ response: Lam D, Blah TR, Francis IC. Letter to the Editor regarding the publication: “The clinical and pathogenic spectrum of surgically-induced scleral necrosis”
  16. Higher-order Aberrations and their Visual Impact in Paediatric Blepharokeratoconjunctivitis.
  17. Reproducibility, Repeatability, and Correlation of Central Corneal Thickness Measurement with the Pentacam Scheimpflug System and Ultrasound Pachymetry
  18. Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review
  19. Risk factors for secondary Glaucoma in patients with Vogt-Koyanagi-Harada disease
  20. High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease
  21. Burden and depression among informal caregivers of visually impaired patients in Mexico
  22. Age-related Changes of the Corneal Endothelium in the Hispanic Elderly Population
  23. Rheumatoid arthritis-associated peripheral ulcerative keratitis outcomes after early immunosuppressive therapy
  24. A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel
  25. The evolution of the modified osteo-odonto-keratoprosthesis, its reliability, and long-term visual rehabilitation prognosis: An analytical review
  26. Dry eye disease, a prominent manifestation of systemic autoimmune disorders
  27. Spontaneous corneal perforation in chronic trachoma
  28. Update on indications, complications, and outcomes of scleral contact lenses
  29. Current practice in the management of ocular toxoplasmosis
  30. Simultaneous clinical presentation of Vogt-Koyanagi-Harada disease and ocular tuberculosis: A diagnostic and therapeutic challenge
  31. Demographic profile and clinical course of Fuchs endothelial corneal dystrophy in Mexican patients
  32. Infectious Eye Diseases - Recent Advances in Diagnosis and Treatment
  33. Contact Lens-Associated Infectious Keratitis: Update on Diagnosis and Therapy
  34. Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications
  35. Pigment dispersion syndrome and its implications for glaucoma
  36. The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review
  37. Demographic Profile and Clinical Course of Fuchs Endothelial Corneal Dystrophy in Mexican Patients.
  38. The impact of central foveal thickness and integrity of the outer retinal layers in the visual outcome of uveitic macular edema
  39. Digital Image Processing and Development of Machine Learning Models for the Discrimination of Corneal Pathology: An Experimental Model
  40. Anterior-segment optical coherence tomography for the detection and therapeutic monitoring of corneal disorders
  41. Digital Image Processing and Development of Machine Learning Models for the Discrimination of Corneal Pathology: An Experimental Model
  42. Ramsay Hunt syndrome in a young COVID-19 patient
  43. The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review
  44. In-Vivo AS-OCT Microstructural Analysis of Herpetic Keratitis
  45. Evaluating glaucoma during the times of Covid-19: simple measures may save lives!
  46. Analysis of ocular surface damage and visual impact in patients with primary and secondary Sjögren syndrome
  47. Age-related changes of the corneal endothelium in a Hispanic elderly population.
  48. Multidisciplinary management of neurotrophic and exposure keratopathy.
  49. Introductory Chapter: Current and Future Trends in the Diagnosis and Management of Uveitis
  50. Cogan-Reese Syndrome Multimodal Imaging Analysis: OCT, UBM, and SM.
  51. ​Risk factors for ocular surface damage in dry eye
  52. Intraocular pressure variation during episodes of pigment dispersion and its relationship with the development of pigmentary glaucoma
  53. Somatolactogens and diabetic retinopathy
  54. Cataract Surgery in Patients with Uveitis: Preoperative and Surgical Considerations
  55. Efficacy and safety of pop-titrated versus fixed-energy trans-scleral diode laser cyclophotocoagulation for refractory glaucoma
  56. IL-1α and MMP-9 Tear Levels of Patients with Active Ocular Rosacea before and after Treatment with Systemic Azithromycin or Doxycycline
  57. IL-1α- und MMP-9-Konzentration in der Tränenflüssigkeit von Patienten mit aktiver okulärer Rosazea vor und nach Behandlung mit systemischem Azithromycin oder Doxycyclin
  58. Emergence of solitary juvenile xanthogranuloma on the corneoscleral limbus
  59. Eficacia del diclofenaco tópico vs. nepafenaco tópico en la reducción del dolor durante la fotocoagulación panretiniana
  60. Variación de la presión intraocular durante episodios de dispersión pigmentaria y su relación con el desarrollo de glaucoma pigmentario
  61. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis
  62. Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery
  63. In Response to: “Baddar D, Goldstein DA. HLA-A29-positive Birdshot Chorioretinopathy in a Hispanic Patient”
  64. Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome
  65. Síndrome erosivo corneal recurrente enmascarado como queratitis epitelial herpética
  66. Trans-scleral diode laser cyclophotocoagulation for refractory glaucoma after high-risk penetrating keratoplasty
  67. The Importance of an Ophthalmologic Examination in Patients With Juvenile Idiopathic Arthritis
  68. Importancia de la evaluación oftalmológica en pacientes con artritis idiopática juvenil
  69. Blefaroqueratoconjuntivitis estafilocócica en la edad pediátrica
  70. Amantadine Corneal Toxicity:Case Report and Review of the Literature
  71. Importancia del escrutinio para tuberculosis previo a la administración de agentes anti-TNF-α en uveítis: a propósito de un caso clínico
  72. Blepharokeratoconjunctivitis in pediatric patients: risk of corneal involvement and visual outcome
  73. Eficacia del ganciclovir tópico como alternativa terapéutica de la queratitis epitelial herpética
  74. Chapter-73 Serpiginous Choroiditis
  75. Pigment Dispersion Syndrome Masquerading as Acute Anterior Uveitis
  76. Secondary Glaucoma in Patients with Uveitis
  77. Outcomes in anterior uveitis associated with the HLA-B27 haplotype
  78. Recurrent uveitis in a patient with adult onset cyclic neutropenia associated with increased large granular lymphocytes
  79. The Value of Combined Serum Angiotensin-Converting Enzyme and Gallium Scan in Diagnosing Ocular Sarcoidosis
  80. Visual acuity and retinoscopy of preterm and full-term infants during the first year of life
  81. Herpes Zoster Peripheral Ulcerative Keratitis in Patients with the Acquired Immunodeficiency Syndrome
  82. Referral Patterns of Uveitis in a Tertiary Eye Care Center
  83. Systemic Drug Toxicity Trends in immunosuppressive Therapy of Immune and Inflammatory Ocular Disease
  84. Disease Relapse in Patients with Ocular Manifestations of Wegener Granulomatosis
  85. Low-dose Cyclosporin A Therapy in Treating Chronic, Noninfectious Uveitis
  86. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir
  87. The Value of Combined Serum Angiotensin-converting Enzyme and Gallium Scan in Diagnosing Ocular Sarcoidosis
  88. Systemic Immunosuppressive Therapy and the Occurrence of Malignancy in Patients with Ocular Inflammatory Disease
  89. Resistance to herpes stromal keratitis conferred by an lgG2a-derived peptide
  90. Increasing the Diagnostic Yield of Conjunctival Biopsy in Patients with Suspected Ocular Cicatricia1 Pemphigoid
  91. Disease Relapse in Patients with Ocular Manifestations of Wegener Granulomatosis
  92. Common major histocompatibility complex class II markers in clinical variants of cicatricial pemphigoid.
  93. Posterior Segment Ocular Manifestations in Patients with HLA-B27—associated Uveitis
  94. Low-dose Cyclosporine Therapy in the Treatment of Birdshot Retinochoroidopathy
  95. Atopic keratoconjunctivitis
  96. Transitory cortical blindness post-trauma.
  97. The role of Igh-1 disparate congenic mouse T lymphocytes in the pathogenesis of herpetic stromal keratitis
  98. Cyclic nucleotide mediators in latency and reactivation​ of HSV-1
  99. Ocular Manifestations​ of Systemic Granulomatous Diseases
  100. Ocular Rosacea